Search Results 91-100 of 16722 for GLP-1 agonists
Mishra S, Persons PA, Bersoux S. Should glucagon-like peptide 1 receptor agonists be withheld during the preoperative period? Cleve Clin J Med. 2025 Apr 1; 92 ( ...
GLP-1 Receptor Agonists and Clinical Outcomes in Patients with Type 2 Diabetes Undergoing Transcatheter Aortic Valve Implantation. Eur Heart J Qual Care ...
Thyroid Cancer Risk with GLP-1 Receptor Agonists: Evidence, Knowledge Gaps, and the Path Forward. Thyroid. 2025 Jan; 35 (1):3-5 Epub 2025 Jan 08. View PubMed ...
GLP-1 agonist use. Patients on medications related to metabolic syndrome where dose adjustments are planned to be made during the study period. Note: Other ...
Mayo Clinic Transplant Center's patient-centric design allows patients and caregivers to stay in one ... "We have found use of GLP-1 receptor agonists and SGLT2 ...
Taking a GLP-1 agonist < 6 months. Taking prescription or over-the-counter medications for weight loss in the last 3 months before screening, or planning to ...
GLP-1 Agonists for Weight Loss: Do They Increase Complications in Non-diabetic Patients Undergoing Primary Total Hip Arthroplasty? J Arthroplasty. 2025 Aug ...
2026 Jan 29; 21(1):33. View PubMed; Eshak N, Irani A, Sullivan M. Exploring the effects of GLP-1 receptor agonists in fibromyalgia: a propensity-matched real ...
Hunter Guevara LR, Beam WBB, Pasternak JJ. To the Brain and Beyond: Neurological Implications of Glucagon-Like Peptide-1 Receptor Agonists.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.